Key result
Ibudilast administration for 18 months lowered urinary albumin excretion compared to controls in type 2 diabetes patients with microalbuminuria.
Why the study?
Does ibudilast reduce urinary albumin excretion in nonhypertensive patients with type 2 diabetes mellitus and microalbuminuria?
Observational (n=16)
Does ibudilast reduce urinary albumin excretion in nonhypertensive patients with type 2 diabetes mellitus and microalbuminuria?
Ibudilast significantly reduced urinary albumin excretion over 18 months in a small cohort of nonhypertensive patients with type 2 diabetes, suggesting a potential role in slowing early diabetic nephropathy.
Answers are grounded in this paper and cite their sources.
Ibudilast was associated with lower albuminuria in this cohort; hypothesis-generating for early diabetic nephropathy and should not yet change practice.
To evaluate the clinical effect of ibudilast, a prostacyclin-mediated vasodilator and antiplatelet agent, on diabetic nephropathy, 8 nonhypertensive patients with type 2 diabetes mellitus (DM; 4 men and 4 women, mean age: 58.9 +/- 11.4 years, duration of diabetes: 16.9 +/- 3.2 years) with microalbuminuria [20-200 mg/g creatinine (Cr)] were administered ibudilast (30 mg/day) for 18 months (ibudilast group). The urinary albumin excretion index (UAE, mg albumin/g Cr) was compared with 8 age-matched type 2 DM with microalbuminuria (control group). During the study, the UAE significantly decreased in the ibudilast group, while it significantly increased in the control group. After 18 months, the UAE (52 +/- 19 mg/g Cr) in the ibudilast group was significantly (p < 0.05) lower than that (99 +/- 46 mg/g Cr) in the control group. These results suggest that ibudilast may inhibit the progression of early diabetic nephropathy in type 2 DM.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (2002) conducted an observational in Type 2 Diabetes mellitus with Microalbuminuria (n=16). Ibudilast vs. Age-matched type 2 DM with microalbuminuria was evaluated on Urinary albumin excretion index (UAE, mg albumin/g Cr) (p=< 0.05). Ibudilast administration for 18 months lowered urinary albumin excretion compared to controls in type 2 diabetes patients with microalbuminuria.
Synapse has enriched 10 related papers. Consider them for comparative context: